Go backIncome
Assets
Total liabilities
Employees
Vesalius Biocapital II ARKIV
Vesalius Biocapital II ARKIV
is in process of liquidation on Jun 15, 2024
To view all financial indicators, unlock this company.
Income
Financial indicator20192018
Cost of sales
-
-
Non-recurring operating expenses
-
(1.20M EUR)
Operating profit
░░░░░░░░
0%
░░░░░░░░
0%
Financial income
░░░░░░░░
0%
░░░░░░░░
0%
Recurring financial income
░░░░░░░░
0%
░░░░░░░░
0%
Non-recurring financial income
░░░░░░░░
0%
░░░░░░░░
0%
Financial expenses
░░░░░░░░
0%
░░░░░░░░
0%
Recurring financial expenses
░░░░░░░░
0%
░░░░░░░░
0%
Non-recurring financial expenses
(2.35M EUR)
-
Profit before tax
░░░░░░░░
0%
░░░░░░░░
0%
Net profit
-2.48M EUR
-92%
-1.29M EUR
-159%
Profit (Loss) to be allocated
░░░░░░░░
0%
░░░░░░░░
0%
Profit (Loss) for the year to be allocated
░░░░░░░░
0%
░░░░░░░░
0%
Profit (Loss) brought forward from the previous year
░░░░░░░░
0%
░░░░░░░░
0%
Assets
Financial indicator20192018
Total assets
3.36M EUR
-34%
5.08M EUR
-21%
Non-current assets
░░░░░░░░
0%
░░░░░░░░
0%
Current assets
░░░░░░░░
0%
░░░░░░░░
0%
Total liabilities
Financial indicator20192018
Total liabilities
░░░░░░░░
0%
░░░░░░░░
0%
Equity
░░░░░░░░
0%
░░░░░░░░
0%
Debts
░░░░░░░░
0%
░░░░░░░░
0%
Your trusted source for business data
Socials
English, USA
English, USA